Perspective Therapeutics, Inc.
CATX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $62 | $9 | $21 | $60 |
| Short-Term Investments | $165 | $0 | $23 | $0 |
| Receivables | $0 | $1 | $1 | $2 |
| Inventory | $0 | $0 | $1 | $1 |
| Other Curr. Assets | $4 | $6 | $7 | $1 |
| Total Curr. Assets | $231 | $17 | $53 | $64 |
| Property Plant & Equip (Net) | $60 | $6 | $2 | $3 |
| Goodwill | $0 | $24 | $0 | $0 |
| Intangibles | $50 | $50 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$2 | $1 |
| Total NC Assets | $110 | $81 | $2 | $4 |
| Other Assets | $0 | $0 | $3 | $0 |
| Total Assets | $341 | $98 | $58 | $67 |
| Liabilities | – | – | – | – |
| Payables | $10 | $7 | $2 | $1 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $9 | -$0 | $1 |
| Total Curr. Liab. | $18 | $16 | $3 | $2 |
| LT Debt | $3 | $2 | $0 | $0 |
| Deferred Rev, NC | $27 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $5 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $32 | $7 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $0 | $1 |
| Total Liabilities | $50 | $23 | $3 | $3 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$232 | -$152 | -$106 | -$95 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $522 | $228 | $160 | $159 |
| Total Equity | $291 | $75 | $55 | $64 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $341 | $98 | $58 | $67 |
| Net Debt | -$58 | -$7 | -$21 | -$60 |